NCT02282358View on ClinicalTrials.gov

Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

May 26, 2023

Study Completion Date

May 26, 2023

Conditions
LymphomaRelapsed and RefractoryDiffuse Large B-Cell Lymphoma and Follicular Lymphoma
Interventions
DRUG

Mocetinostat

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

Sponsors

Collaborators (1)

MethylGene Inc.
All Listed Sponsors
collaborator

MethylGene Inc.

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER